Maxidex
- Product NDC
- 0078-0925
- 11-digit product format
- 000780925
- Labeler code
- 0078
- Product ID
- 0078-0925_603f0bac-16b8-42f5-985e-fb0d73ee284d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dexamethasone
- Dosage form
- SUSPENSION/ DROPS
- Route
- OPHTHALMIC
- Labeler
- Novartis Pharmaceuticals Corporation
- Application
- NDA013422
- Marketing category
- NDA
- Marketing start
- 1966-05-15
- Marketing end
- 0000-00-00
- Substance
- DEXAMETHASONE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0078-0925 | MAXIDEX (DEXAMETHASONE) SUSPENSION/ DROPS [NOVARTIS PHARMACEUTICALS CORPORATION] | 3 | Legacy NDC | 20250504_603f0bac-16b8-42f5-985e-fb0d73ee284d.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0078-0925-25 | 00078092525 | 5 mL in 1 BOTTLE (0078-0925-25) | 5 ml | 2022-07-05 | 0000-00-00 | No | No | Current |